Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial

American Heart Journal

Volumn 162, Issue 2, 2011, Pages 382-389

  Disertori, Marcello ^a,d   Lombardi, Federico ^b   Barlera, Simona ^c   Maggioni, Aldo Pietro ^d   Favero, Chiara ^c   Franzosi, Maria Grazia ^c   Lucci, Donata ^d   Staszewsky, Lidia ^c   Fabbri, Gianna ^d   Quintarelli, Silvia ^a   Bianconi, Leopoldo ^e   Latini, Roberto ^c  

^a SANTA CHIARA HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d ANMCO RESEARCH CENTER   (Italy)

^e SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; PLACEBO; VALSARTAN;

AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TELECONSULTATION;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ATRIAL FIBRILLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; INCIDENCE; ITALY; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; TETRAZOLES; VALINE;

EID: 80051667916     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.05.008     Document Type: Article

References (25)

1. A.J. Camm, P. Kirchhof, and G.Y.H. Lip Guidelines for management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 12 2010 1360 1420
2. C. Kerr, J. Boone, and S. Connolly Follow-up of atrial fibrillation: the initial experience of the Canadian registry of atrial fibrillation Eur Heart J 17 Suppl C 1996 48 51 (Pubitemid 26254723)
3. R. Nieuwlaat, A. Capucci, and A.J. Camm Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation Eur Heart J 26 2005 2422 2434 (Pubitemid 41552972)
4. G.C. Flaker, K. Belew, and K. Beckman Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Am Heart J 149 2005 657 663
5. T. Fetsch, P. Bauer, and R. Engberding Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial Eur Heart J 25 2004 1385 1394 (Pubitemid 39078247)
6. G. Hindricks, C. Piorkowski, and J. Tanneukl Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence Circulation 112 2005 307 313 (Pubitemid 41022070)
7. M. Patten, R. Maas, and A. Karim Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients; subanalysis of the SOPAT trial J Cardiovasc Electrophysiol 17 2006 1216 1220 (Pubitemid 44583865)
8. J. Pontopiddan, J.C. Nilsen, and S.H. Poulsen Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life PACE 32 2009 717 726
9. P.E.B. Thomsen, C. Jons, and P. Raatikainen Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction. The Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study Circulation 121 2010 258 264
10. P. Defaye, F. Dournaux, and E. Mouton Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study PACE 21 1998 250 255
11. T.V. Glotzer, A.S. Hellkamp, and J. Zimmerman Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the MOde Selection Trial (MOST) Circulation 107 2003 1614 1619 (Pubitemid 36397330)
12. C.W. Israel, G. Gronefeld, and J.R. Ehrlich Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care J Am Coll Cardiol 43 2004 47 52 (Pubitemid 38045914)
13. I. Savelieva, and J. Camm Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management J Interventional Cardiac Electrophysiol 4 2000 369 382
14. P.D. Ziegler, T.V. Glozer, and E.G. Daud Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events Stroke 41 2010 256 260
15. T. Komatsu, H. Tachibana, and Y. Sato Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation Int Heart J 51 2010 98 104
16. The GISSI-AF Investigators Valsartan for prevention of recurrent atrial fibrillation N Engl J Med 360 2009 1606 1617
17. M. Disertori, R. Latini, and A.P. Maggioni Rationale and design of the GISSI-Atrial Fibrillation Trial: randomized, prospective, multicenter study on the use of valsartan, an angiotensin II ATI-receptor blocker, in the prevention of atrial fibrillation recurrence J Cardiovasc Med 7 2006 29 38 (Pubitemid 44132813)
18. B.F. Gage, A.D. Waterman, and W. Shannon Validation of clinical classification schemes for predicting stroke. Results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870 (Pubitemid 32537350)
19. A. Capucci, M. Santini, and L. Padeletti Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers J Am Coll Cardiol 26 2005 1913 1920 (Pubitemid 41579816)
20. I.C. Van Gelder, H.F. Groenveld, and H.J.G.M. Crijns Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 2010 1363 1373
21. P. Dorian, P.G. Guerra, and C.R. Kerr Validation of a new simple scale to measure symptoms in atrial fibrillation Circ Arrhythmia Electrophysiol 2 2009 218 224
22. R. Wolk, P. Kulakowswki, and S. Karczmarewics The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone Int J Cardiol 54 1996 207 211 (Pubitemid 26226632)
23. M. Santini, G.M. De Ferrari, and C. Pandozi Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from atrial Fibrillation/flutter Italian Registry (FIRE) Ital Heart J 5 2004 205 213
24. D. Roy, M. Talajic, P. Dorian for the Canadian Trial of Atrial Fibrillation Investigators Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators N Engl J Med 342 2000 913 920 (Pubitemid 30177051)
25. L. Friberg, N. Hammar, and M. Ringh Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-Study on Atrial Fibrillation (SCAF-study) Eur Heart J 27 2006 1954 1964 (Pubitemid 44297370)